PPM1N
gene geneOn this page
Also known as FLJ40125
Summary
PPM1N (protein phosphatase, Mg2+/Mn2+ dependent 1N (putative), HGNC:26845) is a protein-coding gene on chromosome 19q13.32, encoding Probable protein phosphatase 1N (Q8N819).
Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in positive regulation of canonical Wnt signaling pathway and regulation of canonical NF-kappaB signal transduction. Predicted to be active in cytosol and nucleus.
Source: NCBI Gene 147699 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 80 total
- MANE Select transcript:
NM_001080401
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26845 |
| Approved symbol | PPM1N |
| Name | protein phosphatase, Mg2+/Mn2+ dependent 1N (putative) |
| Location | 19q13.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40125 |
| Ensembl gene | ENSG00000213889 |
| Ensembl biotype | protein_coding |
| Entrez | 147699 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 nonsense_mediated_decay
ENST00000396735, ENST00000396736, ENST00000396737, ENST00000401593, ENST00000401705, ENST00000415077, ENST00000451287, ENST00000456399
RefSeq mRNA: 1 — MANE Select: NM_001080401
NM_001080401
CCDS: CCDS46115
Canonical transcript exons
ENST00000451287 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001560351 | 45502017 | 45502513 |
| ENSE00002323148 | 45498443 | 45499411 |
| ENSE00003524748 | 45499949 | 45500066 |
| ENSE00003525352 | 45500650 | 45500710 |
| ENSE00003601055 | 45500456 | 45500561 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 84.03.
FANTOM5 (CAGE): breadth broad, TPM avg 1.4529 / max 38.1072, expressed in 695 samples.
FANTOM5 promoters (8 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176483 | 0.4709 | 235 |
| 176482 | 0.3833 | 189 |
| 176485 | 0.3122 | 132 |
| 208864 | 0.1371 | 71 |
| 176486 | 0.0441 | 17 |
| 176487 | 0.0408 | 18 |
| 176484 | 0.0388 | 11 |
| 176488 | 0.0257 | 9 |
Top tissues by expression
253 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.03 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.55 | gold quality |
| monocyte | CL:0000576 | 81.59 | gold quality |
| leukocyte | CL:0000738 | 81.26 | gold quality |
| granulocyte | CL:0000094 | 81.15 | gold quality |
| spleen | UBERON:0002106 | 77.84 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 77.29 | gold quality |
| buccal mucosa cell | CL:0002336 | 75.47 | gold quality |
| pancreatic ductal cell | CL:0002079 | 72.35 | silver quality |
| ileal mucosa | UBERON:0000331 | 72.25 | gold quality |
| blood | UBERON:0000178 | 72.17 | gold quality |
| nucleus accumbens | UBERON:0001882 | 69.27 | gold quality |
| skin of abdomen | UBERON:0001416 | 68.97 | gold quality |
| vermiform appendix | UBERON:0001154 | 68.24 | gold quality |
| esophagus mucosa | UBERON:0002469 | 67.93 | gold quality |
| putamen | UBERON:0001874 | 67.84 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 67.82 | gold quality |
| stromal cell of endometrium | CL:0002255 | 67.63 | gold quality |
| skin of leg | UBERON:0001511 | 67.28 | gold quality |
| lymph node | UBERON:0000029 | 67.27 | gold quality |
| esophagus | UBERON:0001043 | 66.88 | gold quality |
| caudate nucleus | UBERON:0001873 | 66.58 | gold quality |
| apex of heart | UBERON:0002098 | 66.48 | gold quality |
| omental fat pad | UBERON:0010414 | 66.43 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 66.37 | gold quality |
| peritoneum | UBERON:0002358 | 66.36 | gold quality |
| lower esophagus | UBERON:0013473 | 66.16 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 66.12 | gold quality |
| bone marrow cell | CL:0002092 | 66.09 | silver quality |
| nasal cavity epithelium | UBERON:0005384 | 65.94 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ENAD-17 | yes | 586.68 |
| E-GEOD-76312 | yes | 29.44 |
| E-ANND-3 | yes | 4.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
41 targeting PPM1N, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-3679-3P | 99.64 | 69.88 | 1599 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-142-5P | 99.48 | 70.92 | 2416 |
| HSA-MIR-5590-3P | 99.48 | 70.91 | 2429 |
| HSA-MIR-6839-3P | 99.39 | 68.86 | 1301 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-155-3P | 99.03 | 67.99 | 924 |
| HSA-MIR-629-5P | 98.78 | 68.72 | 1032 |
| HSA-MIR-655-5P | 98.74 | 65.93 | 888 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
| HSA-MIR-6868-3P | 98.63 | 69.64 | 2259 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
Cross-species orthologs
17 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ppm1na | ENSDARG00000010231 |
| danio_rerio | ppm1nb | ENSDARG00000057032 |
| danio_rerio | ppm1h | ENSDARG00000063684 |
| danio_rerio | ppm1j | ENSDARG00000074690 |
| mus_musculus | Ppm1n | ENSMUSG00000030402 |
| rattus_norvegicus | Ppm1n | ENSRNOG00000058133 |
| drosophila_melanogaster | Pdp | FBGN0029958 |
| drosophila_melanogaster | CG17598 | FBGN0031194 |
| drosophila_melanogaster | CG10376 | FBGN0032702 |
| drosophila_melanogaster | Ppm1 | FBGN0035143 |
| drosophila_melanogaster | CG17746 | FBGN0035425 |
| drosophila_melanogaster | Nil | FBGN0039421 |
| drosophila_melanogaster | alph | FBGN0086361 |
| caenorhabditis_elegans | WBGENE00006460 | |
| caenorhabditis_elegans | WBGENE00016580 | |
| caenorhabditis_elegans | WBGENE00018362 | |
| caenorhabditis_elegans | pdp-1 | WBGENE00022832 |
Paralogs (16): PPM1F (ENSG00000100034), TAB1 (ENSG00000100324), PPM1A (ENSG00000100614), PPM1H (ENSG00000111110), PPM1G (ENSG00000115241), ILKAP (ENSG00000132323), PPM1B (ENSG00000138032), PPM1J (ENSG00000155367), PPM1L (ENSG00000163590), PPM1K (ENSG00000163644), PPM1M (ENSG00000164088), PDP1 (ENSG00000164951), PPM1D (ENSG00000170836), PDP2 (ENSG00000172840), PPM1E (ENSG00000175175), PP2D1 (ENSG00000183977)
Protein
Protein identifiers
Probable protein phosphatase 1N — Q8N819 (reviewed: Q8N819)
All UniProt accessions (5): A8MXX7, B5MCQ2, E7ENL9, Q8N819, H7C347
UniProt curated annotations — full annotation on UniProt →
Cofactor. Binds 2 magnesium or manganese ions per subunit.
Similarity. Belongs to the PP2C family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N819-1 | 1 | yes |
| Q8N819-2 | 2 | |
| Q8N819-3 | 3 |
RefSeq proteins (1): NP_001073870* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001932 | PPM-type_phosphatase-like_dom | Domain |
| IPR012911 | PP2C_C | Domain |
| IPR015655 | PP2C | Family |
| IPR036457 | PPM-type-like_dom_sf | Homologous_superfamily |
| IPR036580 | PP2C_C_sf | Homologous_superfamily |
Pfam: PF00481, PF07830
Catalyzed reactions (Rhea), 2 shown:
- O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate (RHEA:20629)
- O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate (RHEA:47004)
UniProt features (13 total): binding site 5, splice variant 3, region of interest 2, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N819-F1 | 87.36 | 0.78 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (5): 103; 103; 104; 274; 317
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 74 (showing top):
GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY, GOBP_CANONICAL_WNT_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY, CCCNNGGGAR_OLF1_01, CP2_01, GOMF_MAGNESIUM_ION_BINDING, GOMF_MANGANESE_ION_BINDING, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS, GGGGCCC_MIR296, GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY, GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY, MEISSNER_NPC_HCP_WITH_H3K27ME3, MEISSNER_BRAIN_HCP_WITH_H3K27ME3
GO Biological Process (3): regulation of canonical NF-kappaB signal transduction (GO:0043122), positive regulation of canonical Wnt signaling pathway (GO:0090263), protein dephosphorylation (GO:0006470)
GO Molecular Function (6): magnesium ion binding (GO:0000287), protein serine/threonine phosphatase activity (GO:0004722), manganese ion binding (GO:0030145), phosphoprotein phosphatase activity (GO:0004721), hydrolase activity (GO:0016787), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| canonical NF-kappaB signal transduction | 1 |
| regulation of intracellular signal transduction | 1 |
| positive regulation of Wnt signaling pathway | 1 |
| canonical Wnt signaling pathway | 1 |
| regulation of canonical Wnt signaling pathway | 1 |
| dephosphorylation | 1 |
| protein modification process | 1 |
| metal ion binding | 1 |
| phosphoprotein phosphatase activity | 1 |
| transition metal ion binding | 1 |
| phosphatase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1455 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PPM1N | TMEM14A | Q9Y6G1 | 568 |
| PPM1N | FGD6 | Q6ZV73 | 520 |
| PPM1N | COBLL1 | Q53SF7 | 519 |
| PPM1N | GCSAM | Q8N6F7 | 508 |
| PPM1N | CLNK | Q7Z7G1 | 506 |
| PPM1N | GGT5 | P36269 | 471 |
| PPM1N | UPK3A | O75631 | 459 |
| PPM1N | PACSIN1 | Q9BY11 | 451 |
| PPM1N | MCEMP1 | Q8IX19 | 432 |
| PPM1N | PRAM1 | Q96QH2 | 427 |
| PPM1N | LRIT2 | A6NDA9 | 412 |
| PPM1N | TTC17 | Q96AE7 | 401 |
| PPM1N | MS4A10 | Q96PG2 | 400 |
| PPM1N | LPAR2 | Q9HBW0 | 398 |
| PPM1N | KAAG1 | Q9UBP8 | 394 |
IntAct
1 interactions, top by confidence:
BioGRID (3): PPM1N (Proximity Label-MS), PPM1N (Affinity Capture-RNA), UBE2D2 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2A9Q0, A6NED2, A9JSM3, B0BNK7, B7Z1M9, C9JI98, D2HFT7, D4A2Q0, O94819, P0C7J6, P0C7L8, P0CG09, P0CG25, P0DKB5, Q0MW30, Q1RMS4, Q2I0M4, Q2M3D2, Q2MJR0, Q2WF71, Q32NY4, Q5EBP3, Q5PQP9, Q6NY19, Q6P6N5, Q6PJG9, Q6UKI2, Q6ZW31, Q7Z736, Q86UD0, Q8BGL1, Q8BLY3, Q8BNW9, Q8BRJ4, Q8N144, Q8N239, Q8N4B1, Q8N819, Q8QZV0, Q96BM1
Diamond homologs: A0A7U2MSD6, A0BLX0, A0BQL0, A0CUB5, A0DSB3, A0DTY1, A3A8Q4, A3A8W2, A3A8W6, A5PJZ2, F1LNI5, G0RT93, O04719, O15355, O15743, O62829, O62830, O75688, O80871, O81716, P20650, P34221, P35813, P35814, P35815, P36993, P38089, P39966, P40371, P49443, P49444, P49593, P49595, P49596, P49597, P49598, P79126, P93006, Q09172, Q09173
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
80 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 68 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2179 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:45488985:CC:C | acceptor_gain | 1.0000 |
| 19:45488986:CC:C | acceptor_gain | 1.0000 |
| 19:45488986:CCT:C | acceptor_loss | 1.0000 |
| 19:45488988:T:G | acceptor_loss | 1.0000 |
| 19:45489344:A:AC | donor_gain | 1.0000 |
| 19:45489345:C:CC | donor_gain | 1.0000 |
| 19:45495003:CTC:C | acceptor_gain | 1.0000 |
| 19:45495005:CCTGC:C | acceptor_loss | 1.0000 |
| 19:45495006:CTGCA:C | acceptor_loss | 1.0000 |
| 19:45495091:TTACC:T | donor_loss | 1.0000 |
| 19:45495092:TAC:T | donor_loss | 1.0000 |
| 19:45495094:C:CA | donor_loss | 1.0000 |
| 19:45495094:CCTT:C | donor_gain | 1.0000 |
| 19:45495140:C:CC | acceptor_gain | 1.0000 |
| 19:45496902:T:C | donor_gain | 1.0000 |
| 19:45500562:G:GG | donor_gain | 1.0000 |
| 19:45488844:CCA:C | donor_loss | 0.9900 |
| 19:45488845:CA:C | donor_loss | 0.9900 |
| 19:45488846:ACC:A | donor_loss | 0.9900 |
| 19:45488847:CC:C | donor_loss | 0.9900 |
| 19:45488848:C:G | donor_loss | 0.9900 |
| 19:45488982:AGGCC:A | acceptor_gain | 0.9900 |
| 19:45488983:GGCC:G | acceptor_gain | 0.9900 |
| 19:45488984:GCC:G | acceptor_gain | 0.9900 |
| 19:45488985:CCC:C | acceptor_gain | 0.9900 |
| 19:45488987:C:CC | acceptor_gain | 0.9900 |
| 19:45489379:G:GA | donor_gain | 0.9900 |
| 19:45489398:AAAC:A | donor_gain | 0.9900 |
| 19:45493168:C:A | donor_gain | 0.9900 |
| 19:45494264:T:TA | donor_gain | 0.9900 |
AlphaMissense
2719 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:45499189:G:C | K239N | 0.996 |
| 19:45499189:G:T | K239N | 0.996 |
| 19:45499188:A:T | K239M | 0.984 |
| 19:45499290:C:T | S273F | 0.982 |
| 19:45499014:G:T | G181V | 0.979 |
| 19:45499104:T:C | I211T | 0.975 |
| 19:45499274:T:C | F268L | 0.972 |
| 19:45499276:C:A | F268L | 0.972 |
| 19:45499276:C:G | F268L | 0.972 |
| 19:45499100:C:A | R210S | 0.971 |
| 19:45498902:T:C | F144L | 0.970 |
| 19:45498904:C:A | F144L | 0.970 |
| 19:45498904:C:G | F144L | 0.970 |
| 19:45499290:C:A | S273Y | 0.970 |
| 19:45498780:A:T | D103V | 0.969 |
| 19:45499188:A:C | K239T | 0.968 |
| 19:45498713:G:C | D81H | 0.967 |
| 19:45499173:G:T | G234V | 0.966 |
| 19:45499177:C:A | D235E | 0.966 |
| 19:45499177:C:G | D235E | 0.966 |
| 19:45498915:A:T | D148V | 0.965 |
| 19:45499962:A:T | N318I | 0.964 |
| 19:45499980:T:A | V324D | 0.964 |
| 19:45498825:T:C | L118S | 0.963 |
| 19:45499187:A:G | K239E | 0.963 |
| 19:45499968:C:T | T320I | 0.963 |
| 19:45500650:G:C | K388N | 0.963 |
| 19:45500650:G:T | K388N | 0.963 |
| 19:45499236:C:A | P255Q | 0.962 |
| 19:45499018:C:A | D182E | 0.961 |
dbSNP variants (sampled 300 via entrez): RS1000057452 (19:45501428 A>G), RS1000306761 (19:45501879 A>C,G), RS1000534620 (19:45501710 G>A), RS1001466568 (19:45502989 A>T), RS1001731680 (19:45501805 G>A), RS1001750008 (19:45501025 A>G), RS1003404275 (19:45500023 G>A), RS1004077083 (19:45496554 A>G), RS1004149047 (19:45496827 G>A), RS1004275341 (19:45501872 G>A,T), RS1005084582 (19:45497596 G>T), RS1006323354 (19:45500479 C>T), RS1006422068 (19:45500804 A>C), RS1008749688 (19:45497091 C>A), RS1009001078 (19:45498876 G>A)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:604805
GenCC curated gene-disease
Mondo (1): hereditary spastic paraplegia 12 (MONDO:0011489)
Orphanet (1): Autosomal dominant spastic paraplegia type 12 (Orphanet:100993)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007827_3 | Alzheimer’s disease or HDL levels (pleiotropy) | 1.000000e-97 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004612 | high density lipoprotein cholesterol measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C537484 | Spastic paraplegia 12, autosomal dominant (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression | 4 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| sotorasib | affects cotreatment, decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| terbufos | increases methylation | 1 |
| arsenite | increases methylation | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| entinostat | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | increases expression | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Fonofos | increases methylation | 1 |
| Parathion | increases methylation | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TF51 | HAP1 PPM1N (-) 1 | Cancer cell line | Male |
| CVCL_TF52 | HAP1 PPM1N (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hereditary spastic paraplegia 12